238 related articles for article (PubMed ID: 27786256)
1. Infantile Hemangioma Originates From A Dysregulated But Not Fully Transformed Multipotent Stem Cell.
Harbi S; Wang R; Gregory M; Hanson N; Kobylarz K; Ryan K; Deng Y; Lopez P; Chiriboga L; Mignatti P
Sci Rep; 2016 Oct; 6():35811. PubMed ID: 27786256
[TBL] [Abstract][Full Text] [Related]
2. VEGFR-1 mediates endothelial differentiation and formation of blood vessels in a murine model of infantile hemangioma.
Boscolo E; Mulliken JB; Bischoff J
Am J Pathol; 2011 Nov; 179(5):2266-77. PubMed ID: 21945324
[TBL] [Abstract][Full Text] [Related]
3. Infantile hemangioma-derived stem cells and endothelial cells are inhibited by class 3 semaphorins.
Nakayama H; Huang L; Kelly RP; Oudenaarden CR; Dagher A; Hofmann NA; Moses MA; Bischoff J; Klagsbrun M
Biochem Biophys Res Commun; 2015 Aug; 464(1):126-32. PubMed ID: 26086095
[TBL] [Abstract][Full Text] [Related]
4. A switch in Notch gene expression parallels stem cell to endothelial transition in infantile hemangioma.
Wu JK; Adepoju O; De Silva D; Baribault K; Boscolo E; Bischoff J; Kitajewski J
Angiogenesis; 2010 Mar; 13(1):15-23. PubMed ID: 20069356
[TBL] [Abstract][Full Text] [Related]
5. Propranolol Accelerats Hemangioma Stem Cell Transformation Into Adipocyte.
Li HH; Lou Y; Zhang RR; Xie J; Cao DS
Ann Plast Surg; 2019 Nov; 83(5):e5-e13. PubMed ID: 31609806
[TBL] [Abstract][Full Text] [Related]
6. Propranolol Targets Hemangioma Stem Cells via cAMP and Mitogen-Activated Protein Kinase Regulation.
Munabi NC; England RW; Edwards AK; Kitajewski AA; Tan QK; Weinstein A; Kung JE; Wilcox M; Kitajewski JK; Shawber CJ; Wu JK
Stem Cells Transl Med; 2016 Jan; 5(1):45-55. PubMed ID: 26574555
[TBL] [Abstract][Full Text] [Related]
7. Insulin‑like growth factor I promotes adipogenesis in hemangioma stem cells from infantile hemangiomas.
Wang F; Li H; Lou Y; Xie J; Cao D; Huang X
Mol Med Rep; 2019 Apr; 19(4):2825-2830. PubMed ID: 30720075
[TBL] [Abstract][Full Text] [Related]
8. CD133 selected stem cells from proliferating infantile hemangioma and establishment of an in vivo mice model of hemangioma.
Mai HM; Zheng JW; Wang YA; Yang XJ; Zhou Q; Qin ZP; Li KL
Chin Med J (Engl); 2013 Jan; 126(1):88-94. PubMed ID: 23286484
[TBL] [Abstract][Full Text] [Related]
9. Multipotential stem cells recapitulate human infantile hemangioma in immunodeficient mice.
Khan ZA; Boscolo E; Picard A; Psutka S; Melero-Martin JM; Bartch TC; Mulliken JB; Bischoff J
J Clin Invest; 2008 Jul; 118(7):2592-9. PubMed ID: 18535669
[TBL] [Abstract][Full Text] [Related]
10. E-selectin mediates stem cell adhesion and formation of blood vessels in a murine model of infantile hemangioma.
Smadja DM; Mulliken JB; Bischoff J
Am J Pathol; 2012 Dec; 181(6):2239-47. PubMed ID: 23041613
[TBL] [Abstract][Full Text] [Related]
11. Corticosteroid suppression of VEGF-A in infantile hemangioma-derived stem cells.
Greenberger S; Boscolo E; Adini I; Mulliken JB; Bischoff J
N Engl J Med; 2010 Mar; 362(11):1005-13. PubMed ID: 20237346
[TBL] [Abstract][Full Text] [Related]
12. Propranolol inhibits angiogenesis via down-regulating the expression of vascular endothelial growth factor in hemangioma derived stem cell.
Zhang L; Mai HM; Zheng J; Zheng JW; Wang YA; Qin ZP; Li KL
Int J Clin Exp Pathol; 2014; 7(1):48-55. PubMed ID: 24427325
[TBL] [Abstract][Full Text] [Related]
13. Progenitor cells in infantile hemangioma.
Bischoff J
J Craniofac Surg; 2009 Mar; 20 Suppl 1(Suppl 1):695-7. PubMed ID: 19169153
[TBL] [Abstract][Full Text] [Related]
14. The flavonoid luteolin suppresses infantile hemangioma by targeting FZD6 in the Wnt pathway.
Dai Y; Zheng H; Liu Z; Wang Y; Hu W
Invest New Drugs; 2021 Jun; 39(3):775-784. PubMed ID: 33411210
[TBL] [Abstract][Full Text] [Related]
15. α6-Integrin is required for the adhesion and vasculogenic potential of hemangioma stem cells.
Smadja DM; Guerin CL; Boscolo E; Bieche I; Mulliken JB; Bischoff J
Stem Cells; 2014 Mar; 32(3):684-93. PubMed ID: 24022922
[TBL] [Abstract][Full Text] [Related]
16. KLF2 Orchestrates Pathological Progression of Infantile Hemangioma through Hemangioma Stem Cell Fate Decisions.
Chen Q; Rong H; Zhang L; Wang Y; Bian Q; Zheng J
J Invest Dermatol; 2024 Feb; ():. PubMed ID: 38382868
[TBL] [Abstract][Full Text] [Related]
17. Vasculogenesis in infantile hemangioma.
Boscolo E; Bischoff J
Angiogenesis; 2009; 12(2):197-207. PubMed ID: 19430954
[TBL] [Abstract][Full Text] [Related]
18. NOGOB receptor-mediated RAS signaling pathway is a target for suppressing proliferating hemangioma.
Hu W; Liu Z; Salato V; North PE; Bischoff J; Kumar SN; Fang Z; Rajan S; Hussain MM; Miao QR
JCI Insight; 2021 Feb; 6(3):. PubMed ID: 33400686
[TBL] [Abstract][Full Text] [Related]
19. JAGGED1 signaling regulates hemangioma stem cell-to-pericyte/vascular smooth muscle cell differentiation.
Boscolo E; Stewart CL; Greenberger S; Wu JK; Durham JT; Herman IM; Mulliken JB; Kitajewski J; Bischoff J
Arterioscler Thromb Vasc Biol; 2011 Oct; 31(10):2181-92. PubMed ID: 21757656
[TBL] [Abstract][Full Text] [Related]
20. Macrophages Contribute to the Progression of Infantile Hemangioma by Regulating the Proliferation and Differentiation of Hemangioma Stem Cells.
Zhang W; Chen G; Wang FQ; Ren JG; Zhu JY; Cai Y; Zhao JH; Jia J; Zhao YF
J Invest Dermatol; 2015 Dec; 135(12):3163-3172. PubMed ID: 26288359
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
